Sun Pharmaceutical Shows Mixed Performance Amid Broader Sector Trends and Market Dynamics
Sun Pharmaceutical Industries has been active in the pharmaceuticals sector, currently categorized as a large-cap company with a market capitalization of Rs 3,92,879.10 crore. The stock has shown mixed performance trends, with a decline over the past year and year-to-date, while demonstrating significant growth over longer periods.
Sun Pharmaceutical Industries has shown notable activity in the pharmaceuticals and biotechnology sector today, with the stock underperforming the sector by 0.26%. Despite this, the stock has experienced a modest upward trend over the past three days, gaining 0.54% during this period. Currently, Sun Pharmaceutical's market capitalization stands at Rs 3,92,879.10 crore, categorizing it as a large-cap company. The stock's price-to-earnings (P/E) ratio is recorded at 34.36, slightly below the industry average of 35.67.
In terms of moving averages, the stock is performing higher than its 5-day moving average but remains below the 20-day, 50-day, 100-day, and 200-day moving averages, indicating mixed short- to long-term performance trends.
Over the past year, Sun Pharmaceutical has seen a decline of 7.79%, contrasting with the Sensex's modest gain of 0.53%. Year-to-date, the stock has decreased by 13.11%, while the Sensex has increased by 4.32%. In the broader context, the stock has shown significant growth over the past three, five, and ten years, outperforming the Sensex in those time frames.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
